Literature DB >> 9558289

Heterogeneity of hemochromatosis in Italy.

A Piperno1, M Sampietro, A Pietrangelo, C Arosio, L Lupica, G Montosi, A Vergani, M Fraquelli, D Girelli, P Pasquero, A Roetto, P Gasparini, S Fargion, D Conte, C Camaschella.   

Abstract

BACKGROUND & AIMS: Patients with hemochromatosis show variable phenotype expression. We evaluated the frequency of hemochromatosis gene (HFE) mutations and the contribution of HFE genotype, ancestral haplotype, ethnic background, and additional factors (alcohol intake, hepatitis viruses, and beta-thalassemia trait) to the severity of iron overload in a large series of Italian patients with a hemochromatosis phenotype.
METHODS: HFE genotype was studied in 188 patients. Phenotype evaluation was available in 153 men and 20 women and was based mainly on iron removed. HFE genotype was determined by a polymerase chain reaction restriction assay and ancestral haplotype through D6S265 and D6S105 microsatellite analysis.
RESULTS: The frequency of C282Y homozygotes was 64%, with a decreasing gradient from north to south. C282Y homozygotes showed more severe iron overload than the other HFE genotypes. In the same group, ancestral haplotype was associated with a more severe phenotype. Additional factors may favor the development of a relatively mild hemochromatosis phenotype in patients nonhomozygous for the C282Y mutation.
CONCLUSIONS: Hemochromatosis in Italy is a nonhomogenous disorder in which genetic and acquired factors are involved. In patients with a single or no HFE mutation, further studies will enable a differentiation between true genetic disorders and interactions between genetic and acquired factors.

Entities:  

Mesh:

Year:  1998        PMID: 9558289     DOI: 10.1016/s0016-5085(98)70319-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

1.  Should we genetically test everyone for haemochromatosis?

Authors:  K Allen; R Williamson
Journal:  J Med Ethics       Date:  1999-04       Impact factor: 2.903

2.  The origin and spread of the HFE-C282Y haemochromatosis mutation.

Authors:  S Distante; K J H Robson; J Graham-Campbell; A Arnaiz-Villena; P Brissot; Mark Worwood
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

3.  Frequencies of HFE gene mutations associated with haemochromatosis in the population of Libya living in Benghazi.

Authors:  Samir Elmrghni; Ron A Dixon; D Ross Williams
Journal:  Int J Clin Exp Med       Date:  2011-09-15

Review 4.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

5.  Polyneuropathy in idiopathic haemochromatosis.

Authors:  Wieland Hermann; Peter Guenther; Daniel Clark; Armin Wagner
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

6.  Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.

Authors:  Tsung-Jung Lin; Chih-Lin Lin; Chaur-Shine Wang; Shu-O Liu; Li-Ying Liao
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

Review 7.  NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?

Authors:  Shivaram P Singh; Rakesh K Barik
Journal:  J Clin Exp Hepatol       Date:  2019-09-21

8.  Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing.

Authors:  Ludovica Ferbo; Paola M Manzini; Sadaf Badar; Natascia Campostrini; Alberto Ferrarini; Massimo Delledonne; Tiziana Francisci; Valter Tassi; Adriano Valfrè; Anna M Dall'omo; Sergio D'antico; Domenico Girelli; Antonella Roetto; Marco De Gobbi
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

9.  Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

Authors:  Margherita Sini; Orazio Sorbello; Alberto Civolani; Luigi Demelia
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 10.  Screening for hemochromatosis: patients with liver disease, families, and populations.

Authors:  Sumedha P Galhenage; Charlie H Viiala; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.